Holen Sie sich die Stockscreener-App
1.44
1.36%
-0.03
Handel nachbörslich:
1.44
Schlusskurs vom Vortag:
$1.47
Offen:
$1.47
24-Stunden-Volumen:
87,024
Relative Volume:
0.46
Marktkapitalisierung:
$7.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.91M
KGV:
-0.4417
EPS:
-3.26
Netto-Cashflow:
$-6.14M
1W Leistung:
-8.23%
1M Leistung:
-3.97%
6M Leistung:
+9.02%
1J Leistung:
-60.49%
1-Tages-Spanne:
$1.3701
$1.4974
1-Wochen-Bereich:
$1.3701
$1.61
52-Wochen-Spanne:
$1.15
$4.81
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.44 | 8.05M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
How to monitor Galmed Pharmaceuticals Ltd. with trend dashboardsMarket Growth Review & Safe Swing Trade Setups - newser.com
What data driven models say about Galmed Pharmaceuticals Ltd.’s futureIPO Watch & Verified Entry Point Detection - newser.com
Is Galmed Pharmaceuticals Ltd. a candidate for recovery playTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Will Galmed Pharmaceuticals Ltd. benefit from macro trendsJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Applying Elliott Wave Theory to Galmed Pharmaceuticals Ltd.2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressures2025 Key Highlights & Smart Money Movement Alerts - newser.com
What to do if you’re stuck in Galmed Pharmaceuticals Ltd.Chart Signals & Entry Point Confirmation Alerts - newser.com
Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Inflation Watch & Verified Technical Signals - newser.com
Why Galmed Pharmaceuticals Ltd. stock remains on buy listsProfit Target & AI Powered Market Entry Strategies - newser.com
What institutional flow reveals about Galmed Pharmaceuticals Ltd.2025 Price Targets & Community Consensus Picks - newser.com
Building trade automation scripts for Galmed Pharmaceuticals Ltd.July 2025 Patterns & Community Consensus Trade Alerts - newser.com
Is Galmed Pharmaceuticals Ltd. stock a top momentum playJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Galmed Pharmaceuticals Ltd.’s volatility index tracking explainedWeekly Trade Summary & Community Consensus Trade Signals - newser.com
What drives Galmed Pharmaceuticals Ltd stock priceMid Cap Growth Trends & Investment Portfolio Recommendations - earlytimes.in
Understanding Galmed Pharmaceuticals Ltd.’s price movementQuarterly Market Review & Comprehensive Market Scan Reports - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cuts2025 Market Trends & Community Consensus Stock Picks - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Galmed Pharmaceuticals (NASDAQ:GLMD) - Defense World
News impact scoring models applied to Galmed Pharmaceuticals Ltd.Weekly Trading Summary & Verified Momentum Stock Watchlist - newser.com
Will Galmed Pharmaceuticals Ltd. (GPH) stock outperform benchmarksShort Setup & Advanced Technical Analysis Signals - newser.com
What the charts say about Galmed Pharmaceuticals Ltd. todayQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Galmed Pharmaceuticals Ltd. stock prediction for this weekJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Combining machine learning predictions for Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-10-03 05:59:14 - newser.com
Can Galmed Pharmaceuticals Ltd. (GPH) stock withstand sector downturnsSwing Trade & Verified Chart Pattern Trade Signals - newser.com
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):